Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.52%
SPX
+0.54%
IXIC
+0.75%
FTSE
+0.52%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
1.99B
Dividend Yield
0.00%
P/E Ratio
-18.83
EPS
-1.50
Revenue
662.00K
Avg. Volume
2.99M

About

What does CGON do?
CG Oncology, based in Irvine, California, focuses on developing bladder-sparing therapies for bladder cancer and went public on January 25, 2024. Its key candidates include cretostimogene and BOND-003, both targeting non-muscle invasive bladder cancer.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
https://cgoncology.com

Recently from Cashu

No Cashu articles
Cg Oncology currently has no Cashu-related articles
Stocks
Health Care
cgon
Cg Oncology
CGON
+2.38 (+9.13%)
28.46
USD
At close at Jul 17, 20:47 UTC
Summary
News
Signals
Benchmarks
Financials